Response of Photofrin®-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 933-936

  Foster, T H ^a,b   Gibson, S L ^a   Raubertas, R F ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Fluence rate effect; Mesothelioma; Photodynamic therapy

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; HUMAN; LIGHT ABSORPTION; MESOTHELIOMA; MOUSE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR RECURRENCE; XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; NUDE MOUSE; PHOTOCHEMOTHERAPY;

ANIMALS; HUMANS; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029665050     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.184     Document Type: Article

References (18)

1. BELLNIER DA, PROUT GR Jr AND LIN C-W. (1985). Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo. J. Natl Cancer Inst., 74, 617-625.
2. BROOKMEYER R AND CROWLEY J. (1982). A confidence interval for the median survival time. Biometrics, 38, 29-41.
3. CINCOTTA L, FOLEY JW, MACEACHERN T, LAMPROS E AND CINCOTTA AH. (1994). Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Cancer Res., 54, 1249-1258.
4. DAWSON-SAUNDERS B AND TRAPP RG. (1994). Basic and Clinical Biostatistics, 2nd edn. Appleton and Lange: Norwalk.
5. DeLANEY TF, SINDELAR WF, TOCHNER Z, SMITH PD, FRIAUF WS, THOMAS G, DACHOWSKI L, COLE JW, STEINBERG SM AND GLATSTEIN E. (1993). Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys., 25, 445-457.
6. FOSTERTH, MURANT RS, BRYANT RG, KNOX RS, GIBSON SL AND HILF R. (1991). Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res., 126, 296-303.
7. FURUSE K, FUKUOKA M, KATO H, HORAI T, KUBOTA K, KODAMA N, KUSUNOKI Y, TAKIFUJI N, OKUNAKA T, KONAKA C, WADA H AND HAYATA Y. (1993). A prospective phase II study on photodynamic therapy with Photofrin® II for centrally located early-stage lung cancer. J. Clin. Oncol., 11, 1852-1857.
8. GIBSON SL, VANDERMEID KR, MURANT RS AND HILF R. (1990a). Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin® II. Br. J. Cancer, 61, 553-557.
9. GIBSON SL, VANDERMEID KR, MURANT RS, RAUBERTAS RF AND HILF R. (1990b). Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res., 50, 7236-7241.
10. GIBSON SL, FOSTER TH, FEINS RH, RAUBERTAS RF, FALLON MA AND HILF R. (1994). Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br. J. Cancer, 69, 473-481.
11. GOMER CJ. (1991). Preclinical examination of first and second generation photosensitisers used in photodynamic therapy. Photochem. Photobiol., 54, 1093-1107.
12. MARCUS SL. (1992). Photodynamic therapy of human cancer. Proc. IEEE, 80, 869-889.
13. MOAN J. AND SOMMER S. (1984). Action spectra for haematoporphyrin derivative and Photofrin II with respect to sensitization of human cells in vitro to photoinactivation. Photochem. Photobiol., 40, 631-634.
14. NSEYO UO, WHALEN RK AND LUNDAHL SL. (1993). Canine bladder response to red and green light whole bladder photodynamic therapy. Invest. Urol., 41, 392-396.
15. STAR WM, MARIJNISSEN HPA, JANSEN H, KEIJZER M AND van GEMERT MJC. (1987). Light dosimetry for photodynamic therapy by whole bladder irradiation. Photochem. Photobiol., 46, 619-624.
16. TOCHNER Z, MITCHELL JB, SMITH P, HARRINGTON F, GLATSTEIN E, RUSSO D AND RUSSO A. (1986). Photodynamic therapy of ascites tumours within the peritoneal cavity. Br. J. Cancer, 53, 733-736.
17. VAN GEMERT JC, BERENBAUM MC AND GIJSBERS GHM. (1985). Wavelength and light-dose dependence on tumour phototherapy with haematoporphyrin derivative. Br. J. Cancer, 52, 43-49.
18. VAN STAVEREN HJ, BEEK JF, RAMAEKERS JWH, KEIJZER M AND STAR WM. (1994). Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation. Phys. Med. Biol., 39, 947-959.